Evidence map›Paper›PMID 31221559›Full record

ArticleNeuron2019

High-Frequency Activation of Nucleus Accumbens D1-MSNs Drives Excitatory Potentiation on D2-MSNs.

T Chase Francis, Hideaki Yano, Tyler G Demarest, Hui Shen, Antonello Bonci

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 71 citations in OpenAlex.

  1. Schizophrenia: from mechanism to therapy.Science China. Life sciences · 2026
    Review
  2. Article
  3. Activity-Dependent Regulation of Basal Forebrain Cholinergic Neurons by Striatal Spiny Projection Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  4. Cue-Dependent Fear Learning Drives Nucleus Accumbens Spine Plasticity.bioRxiv : the preprint server for biology · 2026
    Article
  5. Substance P in the lateral hypothalamic area regulates binge-like eating behaviors in mice.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. A Drd1-cre mouse line with nucleus accumbens gene dysregulation exhibits blunted fentanyl seeking.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. How Dopamine Enables Learning from Aversion.Current opinion in behavioral sciences · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Substance P in the medial amygdala regulates aggressive behaviors in male mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

T Chase FrancisIntramural Research Program, Synaptic Plasticity Section, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA.
Hideaki YanoIntramural Research Program, Computational Chemistry and Molecular Biophysics Unit, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA.
Tyler G DemarestLaboratory of Molecular Gerontology, National Institute on Aging, NIH, Baltimore, MD 21224, USA; Laboratory of Neurosciences, National Institute on Aging, NIH, Baltimore, MD 21224, USA.
Hui ShenIntramural Research Program, Synaptic Plasticity Section, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA.
Antonello BonciIntramural Research Program, Synaptic Plasticity Section, National Institute on Drug Abuse, NIH, Baltimore, MD 21224, USA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA; Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Neuroscience, School of Medicine, Georgetown University Medical Center, Washington, DC, USA; Department of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA. Electronic address: antonello.bonci@nih.gov.
National Institute on Drug Abuse · USGeorgetown University Medical Center · USNational Institute on Aging · US

Funding

Stimulation of Nucleus Accumbens D1-MSNs Produces Lateral Excitation through Substance P ReleaseZIADA000619 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BONCI, ANTONELLO · 2017 to 2019
$717k
Synaptic and Local Network Mechanisms Underlying Nucleus Accumbens High Frequency StimulationFI2GM128622 · NIGMS · U.S. NATIONAL INSTITUTE ON DRUG ABUSE · PI FRANCIS, TANNER CHASE · 2018 to 2018
–
Intramural NIH HHS Z99 AG999999NIGMS NIH HHS FI2 GM128622
6 · The paper itself

Abstract

Subtypes of nucleus accumbens medium spiny neurons (MSNs) promote dichotomous outcomes in motivated behaviors. However, recent reports indicate enhancing activity of either nucleus accumbens (NAc) core MSN subtype augments reward, suggesting coincident MSN activity may underlie this outcome. Here, we report a collateral excitation mechanism in which high-frequency, NAc core dopamine 1 (D1)-MSN activation causes long-lasting potentiation of excitatory transmission (LLP) on dopamine receptor 2 (D2)-MSNs. Our mechanistic investigation demonstrates that this form of plasticity requires release of the excitatory peptide substance P from D1-MSNs and robust cholinergic interneuron activation through neurokinin receptor stimulation. We also reveal that D2-MSN LLP requires muscarinic 1 receptor activation, intracellular calcium signaling, and GluR2-lacking AMPAR insertion. This study uncovers a mechanism for shaping NAc core activity through the transfer of excitatory information from D1-MSNs to D2-MSNs and may provide a means for altering goal-directed behavior through coordinated MSN activity.

Indexed as

Action PotentialsAnimalsAprepitantCalcium SignalingCholinergic NeuronsDopaminergic NeuronsExcitatory Postsynaptic PotentialsInterneuronsLong-Term PotentiationMiceMice, Inbred C57BLMotivationNeurokinin-1 Receptor AntagonistsNucleus AccumbensPhotic StimulationPiperidines3-((3,5-bis(trifluoromethyl)phenyl)methyloxy)-2-phenylpiperidineAprepitantNeurokinin-1 Receptor AntagonistsPiperidinesReceptor, Muscarinic M1Receptors, AMPAReceptors, Dopamine D1Receptors, Dopamine D2Receptors, Neurokinin-1Substance PAMPAR insertioncholinergic interneuronsD2-MSNsexcitatory potentiationlong-lasting potentiationmuscarinic receptorsnucleus accumbensphospholipase C signalingsubstance Psynaptic plasticity

Identifiers

PMID31221559
PMCPMC6712577
OpenAlexW2949697576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.